
Phreesia Investors Face July 13 Deadline in Securities Fraud Suit
Investors who purchased Phreesia, Inc. common stock between May 8, 2025, and March 30, 2026, face a July 13, 2026, deadline to apply as lead plaintiff in a pending securities class action. The lawsuit alleges the company concealed slowing demand and weakened pharmaceutical marketing commitments within its Network Solutions segment.






















